期刊文献+

慢性肝损伤对大鼠脑内P-GP及MRP2功能和表达的影响 被引量:5

Effect of chronic liver failure on the function and expression of P-GP and MRP2 in rat brain
下载PDF
导出
摘要 研究硫代乙酰胺(TAA)诱导的慢性肝损伤(CLF)对大鼠脑内P-糖蛋白(P-GP)和多药耐药蛋白2(MRP2)的功能和表达的影响。大鼠腹腔注射TAA(200 mg/kg),每周两次,连续给药12周诱导慢性肝损伤模型。最后1次给药后24 h,静脉注射P-GP底物罗丹明123(Rho 123)和长春新碱(VCR),以及MRP2底物溴磺酞钠(BSP),S-(2,4二硝基苯基)-谷胱甘肽(DNP-SG),测定大脑皮层、海马和血浆中底物浓度,计算其脑组织/血浆浓度比;用Western blot测定脑内P-GP和MRP2的蛋白表达。结果显示CLF显著升高Rho123和VCR的脑组织/血浆浓度比,显著降低BSP和DNP-SG脑组织/血浆浓度比。Western blot结果表明CLF显著下调脑内P-GP的蛋白水平,显著上调脑内MRP2的蛋白水平。实验结果表明,慢性肝损伤下调大鼠脑内P-GP的功能和表达,上调MRP2的功能和表达。 The purpose of the study was to investigate whether chronic liver failure(CLF) induced by thioacetamide(TAA) affected the function and expression of P-glycoprotein(P-GP) and multidrug resistance-associated protein 2(MRP2) in rat brain.CLF was induced by ip injection of TAA(200 mg/kg) twice per week for 12 weeks.The rats were used for further experiments 24 h after the last administration.The function of P-GP and MRP2 in rat brain was determined using the brain-to-plasma ratios of corresponding substrates(rhodamine 123,Rho123 and vincristine,VCR for P-GP;Sulfobromophthalein,BSP and dinitrophenyl-S-glutathione,DNP-SG for MRP2);Western blot was applied to determine the expression of P-GP and MRP2 proteins.The results suggested that CLF increased the brain-to-plasma ratios of Rho 123 and VCR,while decreasing those of BSP and DNP-SG.Western blot results showed that CLF decreased brain P-GP levels,while increasing MRP2 levels.In conclusion,CLF may decrease the function and expression of P-GP,while increaseing the function and expression of MRP2.
出处 《中国药科大学学报》 CAS CSCD 北大核心 2012年第1期64-69,共6页 Journal of China Pharmaceutical University
基金 国家自然科学基金资助项目(No.81072693 No.30873123) 江苏省高等学校优秀科技创新团队资助项目~~
关键词 P-糖蛋白 多药耐药蛋白2 慢性肝损伤 血-脑脊液屏障 P-glycoprotein multidrug resistance-associated protein 2 chronic liver failure blood-brain barrier
  • 相关文献

参考文献23

  • 1Butterworth RF. Role of circulating neurotoxins in the pathogenesis of hepatic encephalopathy:potential for improvement following their removal by liver assist devices [ J ]. Liver Int ,2003,23 (Suppl 3) :5 -9.
  • 2Lv S, Song H, Zhou Y, et al. Tumour necrosis factor-alpha affects blood-brain barrier permeability and tight junction-associated occludin in acute liver failure [ J ]. Liver Int, 2010,30 ( 8 ) : 1 198 - 1 210.
  • 3Hawkins BT, Davis TP. The blood-brain barrier/neurovascular unit in health and disease [ J ]. Pharrruwol Rev,2005,57 (2) :173 - 185.
  • 4Loscher W, Potschka H. Role of drug efflux transporters in the brain for drug disposition and treatment of brain diseases [ J ]. Prog Neurobiol, 2005,76 ( 1 ) : 22 - 76.
  • 5Fromm MF. Importance of P-glycoprotein at blood-tissue barriers [J]. Trends Pharmacol Sci,2004,25(8) :423 -429.
  • 6Schinkel AH. P-Glycoproteln, a gatekeeper in the blood-brain barrier[ J]. Adv Drug Deliv Rev, 1999,36 ( 2/3 ) : 179 - 194.
  • 7Potschka H, Fedrowitz M, Loscher W. Muhidrug resistance protein MRP2 contributes to blood-brain barrier function and restricts antiepileptic drug activity [ J ]. J Pharmacol Exp Ther , 2003,306( 1 ) : 124 - 131.
  • 8Jing X, Liu X, Wen T, et al. Combined effects of epileptic seizure and phenobarbital induced overexpression of P-glycoprotein in brain of chemically kindled rats [ J ]. Br J Pharmacol,2010,159 (7) :1 511 -1 522.
  • 9Liu H,Xu X, Yang Z, et al. Impaired function and expression of P-glycoprotein in blood-brain barrier of streptozotocin-induced diabetic rats[J]. Brain Res,2006,1 123( 1 ) :245 -252.
  • 10Liu XD, Pan GY, Xie L, et al. Cyelosporin A enhanced protection of nimodipine against brain damage induced by hypoxia-ischemia in mice and rats [ J ]. Acta Phartruwol Sin, 2002,23 ( 3 ) : 225 - 229.

同被引文献37

引证文献5

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部